Alfred M. Ajami

1.1k total citations
35 papers, 909 citations indexed

About

Alfred M. Ajami is a scholar working on Molecular Biology, Biochemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Alfred M. Ajami has authored 35 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Biochemistry and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Alfred M. Ajami's work include Amino Acid Enzymes and Metabolism (9 papers), Metabolism and Genetic Disorders (7 papers) and Neurobiology and Insect Physiology Research (6 papers). Alfred M. Ajami is often cited by papers focused on Amino Acid Enzymes and Metabolism (9 papers), Metabolism and Genetic Disorders (7 papers) and Neurobiology and Insect Physiology Research (6 papers). Alfred M. Ajami collaborates with scholars based in United States, France and Germany. Alfred M. Ajami's co-authors include Vernon R. Young, Lynn M. Riddiford, Michael J. Menconi, Carrie A. Sims, Mitchell P. Fink, Somkiat Wattanasirichaigoon, Louis Beaumier, Antoine E. El-Khoury, Cornelia C. Metges and Leticia Castillo and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Immunology and Gastroenterology.

In The Last Decade

Alfred M. Ajami

35 papers receiving 852 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alfred M. Ajami United States 14 252 180 157 140 137 35 909
Michael Boll Germany 22 542 2.2× 102 0.6× 137 0.9× 64 0.5× 52 0.4× 34 1.3k
Doreen P. West United Kingdom 8 302 1.2× 106 0.6× 131 0.8× 108 0.8× 40 0.3× 12 704
M. L. G. Gardner United Kingdom 17 349 1.4× 60 0.3× 321 2.0× 188 1.3× 42 0.3× 48 1.1k
S. Raghupathi Rami Reddy India 14 326 1.3× 87 0.5× 168 1.1× 29 0.2× 86 0.6× 43 678
I. Trautschold Germany 19 488 1.9× 81 0.5× 129 0.8× 59 0.4× 35 0.3× 84 1.3k
Ines Witte Germany 12 291 1.2× 125 0.7× 51 0.3× 59 0.4× 51 0.4× 14 898
Omar J. Rimoldi Argentina 18 383 1.5× 83 0.5× 132 0.8× 83 0.6× 46 0.3× 38 701
Josep M. Fernández‐Novell Spain 22 465 1.8× 38 0.2× 136 0.9× 66 0.5× 59 0.4× 40 1.3k
G. L. Laqueur United States 18 322 1.3× 133 0.7× 73 0.5× 39 0.3× 69 0.5× 35 1.2k
Karen H. Hales United States 22 775 3.1× 102 0.6× 178 1.1× 100 0.7× 35 0.3× 38 2.0k

Countries citing papers authored by Alfred M. Ajami

Since Specialization
Citations

This map shows the geographic impact of Alfred M. Ajami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfred M. Ajami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfred M. Ajami more than expected).

Fields of papers citing papers by Alfred M. Ajami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfred M. Ajami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfred M. Ajami. The network helps show where Alfred M. Ajami may publish in the future.

Co-authorship network of co-authors of Alfred M. Ajami

This figure shows the co-authorship network connecting the top 25 collaborators of Alfred M. Ajami. A scholar is included among the top collaborators of Alfred M. Ajami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfred M. Ajami. Alfred M. Ajami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Yun, et al.. (2012). A New Rip2 Kinase Inhibitor for the Treatment of Intestinal Inflammation (169.5). The Journal of Immunology. 188(1_Supplement). 169.5–169.5. 2 indexed citations
2.
Sidhu, Maninder K., Carmen Alonso, Bayasi Guleng, et al.. (2011). Small molecule tyrosine kinase inhibitors for the treatment of intestinal inflammation. Inflammatory Bowel Diseases. 17(12). 2416–2426. 14 indexed citations
3.
Chau, MyDoanh, et al.. (2007). Amonafide, a topoisomerase II inhibitor, is unaffected by P-glycoprotein-mediated efflux. Leukemia Research. 32(3). 465–473. 23 indexed citations
4.
Chau, MyDoanh, et al.. (2006). The imidazoacridinone, C-1311 (Symadex™): The first of a potent new class of FLT3 inhibitors. Clinical Cancer Research. 12. 4 indexed citations
5.
Scrimshaw, Nevin S., et al.. (2006). Vernon R Young: the man, the scientist, the visionary. American Journal of Clinical Nutrition. 83(2). 496S–499S. 2 indexed citations
6.
Ajami, Alfred M., et al.. (2001). Metabolism 2000: the emperor needs new clothes. Proceedings of The Nutrition Society. 60(1). 27–44. 12 indexed citations
7.
Young, Vernon R. & Alfred M. Ajami. (2001). Glutamine: The Emperor or His Clothes?. Journal of Nutrition. 131(9). 2449S–2459S. 112 indexed citations
8.
Sims, Carrie A., Somkiat Wattanasirichaigoon, Michael J. Menconi, Alfred M. Ajami, & Mitchell P. Fink. (2001). Ringer’s ethyl pyruvate solution ameliorates ischemia/reperfusion-induced intestinal mucosal injury in rats. Critical Care Medicine. 29(8). 1513–1518. 179 indexed citations
9.
El-Khoury, Antoine E., Paulo Pereira, Sudhir Borgonha, et al.. (2000). Twenty-four–hour oral tracer studies with l-[1-13C]lysine at a low (15 mg • kg−1 • d−1) and intermediate (29 mg • kg−1 • d−1) lysine intake in healthy adults. American Journal of Clinical Nutrition. 72(1). 122–130. 24 indexed citations
10.
Young, Vernon R. & Alfred M. Ajami. (2000). Glutamate: An Amino Acid of Particular Distinction. Journal of Nutrition. 130(4). 892S–900S. 99 indexed citations
11.
Young, Vernon R. & Alfred M. Ajami. (1999). 1999 Jonathan E. Rhoads lecture. Isotopic Metaprobes, Nutrition, and the Roads Ahead. Journal of Parenteral and Enteral Nutrition. 23(4). 175–194. 17 indexed citations
12.
Metges, Cornelia C., Yong‐Ming Yu, Wei Cai, et al.. (1999). Plasma L-5-Oxoproline Carbon and Nitrogen Kinetics in Healthy Young Adults. Journal of Nutrition. 129(11). 1998–2004. 10 indexed citations
13.
El-Khoury, Antoine E., Aníbal Basile-Filho, Louis Beaumier, et al.. (1998). Twenty-four–hour intravenous and oral tracer studies with L-[1-13C]-2-aminoadipic acid and L-[1-13C]lysine as tracers at generous nitrogen and lysine intakes in healthy adults. American Journal of Clinical Nutrition. 68(4). 827–839. 24 indexed citations
14.
Beaumier, Louis, Leticia Castillo, Yong Yu, Alfred M. Ajami, & Vernon R. Young. (1996). Arginine: new and exciting developments for an "old" amino acid.. PubMed. 9(2-3). 296–315. 49 indexed citations
15.
Ajami, Alfred M., et al.. (1989). Synthesis of [1, 2‐13C2]‐S‐Lysine Hydrochloride. Journal of the Chinese Chemical Society. 36(5). 479–481. 2 indexed citations
16.
Ajami, Alfred M., et al.. (1984). Synthesis of [1,2,3,4,5‐13C5] palmitic acid. Journal of Labelled Compounds and Radiopharmaceuticals. 21(6). 525–532. 3 indexed citations
17.
Ajami, Alfred M., et al.. (1983). Synthesis of [2‐13C]phenol (1). Journal of Labelled Compounds and Radiopharmaceuticals. 20(12). 1349–1354. 2 indexed citations
18.
Riddiford, Lynn M., Alfred M. Ajami, & Christine R. B. Boake. (1975). Effectiveness of Insect Growth Regulators in the Control of Populations of the German Cockroach1. Journal of Economic Entomology. 68(1). 46–48. 11 indexed citations
19.
Ajami, Alfred M. & Lynn M. Riddiford. (1973). Comparative metabolism of the Cecropia juvenile hormone. Journal of Insect Physiology. 19(3). 635–645. 106 indexed citations
20.
Riddiford, Lynn M. & Alfred M. Ajami. (1971). Identification of an ommochrome in the eyes and nervous systems of saturniid moths. Biochemistry. 10(8). 1451–1455. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026